Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL
GSK-2334470
CAS Number: 4079-26-9
[Effects of transforming growth factor β1 receptor inhibitor SD-208 on human hypertrophic scar]
CEP-32496 Hydrochloride - CAS# 1227678-26-3 entin enacarbil Imatinib (STI571) is an orallyAgerafenib, also known as RXDX 105, CEP 32496 and AC013773, is an orally available v raf murine sarcoma viral oncogene homolog B1 (B raf) serine threonine protein kinase inhibitor with potential antineoplastic activity. CEP 32496 specifically and selectively inhibits the activity of the mutated form (V600E) of B raf kinase. This inhibits the activation of the RAF mitogen activated protein kinase kinase (MEK) extracellular signal related kinase (ERK)
US$ 356.48
US$ 94.95
US$ 94.95
US$ 98.95
US$ 163.77
US$ 94.95